STOCK TITAN

Vogenx awards director Pieraccini 50,000 options

The award vests in annual installments through October 2, 2029, subject to the director's continued service through each vesting date.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Vogenx, Inc. director Peter Pieraccini received a direct award of 50,000 stock options to acquire common stock on October 2, 2026. The options have an exercise price of $18.23 per share and expire on October 2, 2036. They vest in three annual installments, subject to his continued service through each vesting date. Pieraccini's reported direct option position after the award was 50,000 options.

Insider Pieraccini Peter
Role Director
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) F1 50,000 $0.00 $0.00
Holdings After Transaction: Stock Option (Right to Buy) — 50,000 contracts (Direct)
Footnotes (1)
  1. F1. The options vest over a three -year period in three equal annual installments of 33.33% (16,666 shares on October 2, 2027, 16,667 shares on October 2, 2028 and 16,667 shares on October 2, 2029), subject to the Reporting Person's continued service to the Issuer through each vesting date.
Option award 50,000 stock options Awarded October 2, 2026
Exercise price $18.23 per share Price to exercise the options
Direct option position after award 50,000 options Reported following the award
Option expiration October 2, 2036 Expiration date
First vesting installment 16,666 shares October 2, 2027
Second vesting installment 16,667 shares October 2, 2028
Third vesting installment 16,667 shares October 2, 2029
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy)"
exercise price financial
"exercise price of $18.23 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
annual installments technical
"three equal annual installments of 33.33%"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options did VOGX director Peter Pieraccini receive?

Vogenx director Peter Pieraccini received 50,000 stock options on October 2, 2026. The options cover common stock, have an exercise price of $18.23 per share, and expire on October 2, 2036.

When do Peter Pieraccini's VOGX options vest?

The options vest in annual installments of 16,666 shares on October 2, 2027, 16,667 shares on October 2, 2028, and 16,667 shares on October 2, 2029. Vesting is subject to Pieraccini's continued service through each vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Pieraccini Peter

(Last)(First)(Middle)
C/O VOGENX, INC
PO BOX 19469

(Street)
RALEIGH NORTH CAROLINA 27619

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Vogenx, Inc. [ VOGX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$18.2310/02/2026A50,000 (1)10/02/2036Common Stock50,000$050,000D
Explanation of Responses:
1. The options vest over a three -year period in three equal annual installments of 33.33% (16,666 shares on October 2, 2027, 16,667 shares on October 2, 2028 and 16,667 shares on October 2, 2029), subject to the Reporting Person's continued service to the Issuer through each vesting date.
/s/ Steven R. Delmar, Attorney-in-Fact for Peter Pieraccini10/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading